Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer

    NEXT STORY
    Oncology Venture advancing towards next milestone in its clinical development of IXEMPRA®.
    PREV STORY
    Innate Pharma third quarter 2019 report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AIT Therapeutics Presents On-Demand Nitric Oxide Study and Poster at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland

    author_avatar
    NASDAQ Market News

    Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the 2018 American Society for Clinical Oncology Annual Meeting

    Abstract Data Show Overall Response Rate of 60% in 25 Advanced Melanoma Patients Naïve ...

    author_avatar
    NASDAQ Market News

    Inovio Pharmaceuticals Completes Acquisition of Needle-Free Injection Technology

    PLYMOUTH MEETING, Pa., May 02, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

    author_avatar
    NASDAQ Market News